Back to TB Tweedy, Browne Co LLC

IONS

Showing 9 of 19 quarters

Position history for TBTweedy, Browne Co LLC's holdings in Ionis Pharmaceuticals, Inc.

Yes. Tweedy, Browne holds 1,793,400 shares of IONS (Ionis Pharmaceuticals), worth $80.1M, as of its Q3 2026 13F filing. It reduced the position by 486,911 shares (-21.4%) from Q2 2026. Tweedy, Browne has held IONS since Q1 2022, across 19 quarterly 13F filings. IONS is 6.5% of Tweedy, Browne's reported 13F portfolio.

Current Value

$80.1M

Current Shares

1.8M

Total Value Change

-$58.3M

Total Shares Change

-1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
1.8M
-21.4%
$80.1M6.5%$44.65
0
2026-Q2
Increased
2.3M
+0.2%
$180.8M13.7%$79.29
59
2026-Q1
Decreased
2.3M
-7.7%
$170.9M13.6%$75.09
0
2025-Q4
Decreased
2.5M
-15.0%
$195M15.7%$79.11
0
2025-Q3
Increased
2.9M
+0.3%
$189.8M16.5%$65.42
59
2025-Q2
Decreased
2.9M
-3.1%
$114.3M10.6%$39.51
0
2025-Q1
Decreased
3M
-8.2%
$90M8.0%$30.17
0
2024-Q4
Decreased
3.2M
-6.0%
$113.6M7.7%$34.96
0
2024-Q3
Unchanged
3.5M
0.0%
$138.4M6.6%$40.06
0

Other major holders of IONS: FMR LLC, Capital World Investors

Optional analytics helps us improve. How it’s used